Page last updated: 2024-12-10

2-heptenal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-heptenal: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hept-2-enal : An enal consisting of hept-2-ene having an oxo group at the 1-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(E)-hept-2-enal : A monounsaturated fatty aldehyde that is (2E)-hept-2-ene which is carrying an oxo group at position 1. Found in the peel of Malaysian pink and white pomelo peel and in the scent gland secretion of the rice stink bug Oebalus pugnax. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5283316
CHEMBL ID454759
CHEBI ID143912
SCHEMBL ID120185
MeSH IDM0177921

Synonyms (67)

Synonym
LS-13308
2463-63-0
2-heptenal
ccris 4566
einecs 242-608-0
einecs 219-563-0
butylacrolein
2-heptenal, (2e)-
(e)-hept-2-enal
trans-2-heptenal
brn 1745160
fema no. 3165
beta-butylacrolein
brn 1700822
ai3-36270
ccris 3505
3-butylacrolein
2-heptenal, (e)-
(e)-2-hepten-1-al
trans-2-heptenal, >=95%, stabilized, fg
LMFA06000019
trans-2-heptenal, 97%
2-hept-enal
hept-2-enal
trans-2-hepten-1-al
(e)-2-heptenal
CHEMBL454759
18829-55-5
H0579
hept-(e)-2-enal
(2e)-hept-2-enal
hept-2(e)-enal
n-hept-trans-2-enal
CHEBI:143912
2-trans-heptenal
(2e)-heptenal
hept-trans-2-enal
heptenal
29381-66-6
3-01-00-03002 (beilstein handbook reference)
unii-4njz8gmq6f
4njz8gmq6f ,
4-01-00-03478 (beilstein handbook reference)
A813217
AKOS015915525
.beta.-butylacrolein
2-heptenal, trans-
2-heptenal [fhfi]
SCHEMBL120185
(e)-hept-2-enal stabilized with alpha-tocopherol
DTXSID4062436
W-107756
NDFKTBCGKNOHPJ-AATRIKPKSA-N
(2e)-2-heptenal
heptenal, (e)-
trans-2-heptenal, analytical standard
fema 3165
alpha-heptenal
AS-35008
Q27131340
EN300-119460
Q27260256
(e)-2-hepten-1-al 100 microg/ml in acetonitrile
DTXSID30880832
CS-0185633
EN300-384568
HY-W127398

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" While alpha-pinene and Delta(3)-carene did not induce toxic effects even at exposure concentrations of up to 1800 mg/m(3) and 600 mg/m(3), respectively, hexanal showed a cytotoxic effect at 2000 mg/m(3)."( Cytotoxicity and genotoxicity in human lung epithelial A549 cells caused by airborne volatile organic compounds emitted from pine wood and oriented strand boards.
Gminski, R; Mersch-Sundermann, V; Tang, T, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
uremic toxinA toxin that accumulates in patients with chronic kidney disease.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
enalAn alpha,beta-unsaturated aldehyde of general formula R(1)R(2)C=CR(3)-CH=O in which the aldehydic C=O function is conjugated to a C=C double bond at the alpha,beta position.
monounsaturated fatty aldehydeAny fatty aldehyde with one double or triple bond located at any position in the aliphatic chain.
medium-chain fatty aldehydeAny fatty aldehyde with a chain length between C6 and C12.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1081322Nematicidal activity against Bursaphelenchus xylophilus assessed as mortality at 0.25 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID1081323Nematicidal activity against Bursaphelenchus xylophilus at 0.5 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID1081320Nematicidal activity against Bursaphelenchus xylophilus assessed as mortality at 0.0625 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID1081321Nematicidal activity against Bursaphelenchus xylophilus assessed as mortality at 0.125 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's1 (6.67)18.2507
2000's3 (20.00)29.6817
2010's8 (53.33)24.3611
2020's2 (13.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.95 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index51.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]